Delivery Order SPE2DB20D7059-SPE2DB25FQKF0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,414.63 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) on September 23, 2025, with completion scheduled for September 24, 2025. This competitive award, utilizing firm fixed-price pricing with no set-aside designation, represents a child order under AmerisourceBergen's significantly larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (30-count) with a ceiling value of $1,322.77. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award under open procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $1,064.58 delivery order to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 20 mg capsules (90-count supply) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Esomeprazole Magnesium Delayed Release 20 mg capsules (90-count) with a ceiling value of $19,515.80. This firm fixed price, non-set-aside delivery order is scheduled for completion by August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply under the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules in a 90-count package, with a ceiling value of $2,399.40. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 12, 2025, to supply Esomeprazole Magnesium Delayed Release 20 mg capsules (90-count) with a firm fixed price ceiling value of $3,789.69. The contract is scheduled for completion by September 15, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award represents a competitively awarded, non-set-aside delivery order with no...
- The Defense Logistics Agency awarded a delivery order valued at $1,942.94 to AmerisourceBergen Drug Corp for the supply of esomeprazole magnesium delayed-release 40 mg capsules (30-count units). This order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,408.77 to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 20 mg capsules (90-count supply) on May 30, 2025, with completion targeted for June 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,599.60 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count). The contract, awarded on September 19, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and represents a competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a contract value of $1,660.95. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQKF0Delivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,158.80 for Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) on June 20, 2025, with an ultimate completion date of June 23, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's consistent receipt of competitively awarded delivery orders with firm fixed pricing demonstrates its capability to meet federal procurement requirements. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, which may involve at least three contractors and represents a strategic approach to pharmaceutical supply chain management for military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 6/20/25 |